According to PR-model, Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer is ranked 127,610th in multilingual Wikipedia, in particular this website is ranked 96,677th in English Wikipedia.